U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX1003109: GSM1664137: RNA-seq of control Mutu cells_2; Human gammaherpesvirus 4; RNA-Seq
1 ILLUMINA (Illumina HiSeq 2000) run: 52.2M spots, 5.3G bases, 3.6Gb downloads

Submitted by: NCBI (GEO)
Study: New non-coding lytic transcripts derived from the Epstein Barr virus latency origin of replication oriP are hyper-edited, bind the paraspeckle protein, NONO/p54nrb, and support lytic viral transcription
show Abstracthide Abstract
We have previously shown that the Epstein-Barr virus (EBV) likely encodes hundreds of viral long non-coding RNAs (vlncRNAs) that are expressed during reactivation. Here we show that the EBV latency origin of replication (oriP) is transcribed bi-directionally during reactivation and that both leftward (oriPtLs) and rightward transcripts (oriPtRs) are largely localized in the nucleus. While the oriPtLs are most likely non-coding, at least some of the oriPtRs contain the BCRF1/vIL10 open reading frame. Nonetheless, oriPtR transcripts with long 5'UTRs may partially serve non-coding functions. Both oriPtL and oriPtR transcripts are expressed with late kinetics and their expression is inhibited by phosphonoacetic acid. RNA-seq analysis showed that oriPtLs and oriPtRs exhibited extensive “hyper-editing” at their Family of Repeat (FR) regions. RNA secondary structure prediction revealed that the FR region of both oriPtLs and oriPtRs may form large evolutionarily conserved and thermodynamically stable hairpins. The double-stranded RNA-binding protein and RNA-editing enzyme ADAR was found to bind to oriPtLs, likely facilitating editing of the FR hairpin. Further, the multifunctional paraspeckle protein, NONO, was found to bind to oriPt transcripts suggesting that oriPts interacts with the paraspeckle-based innate anti-viral immune pathway. Knock-down and ectopic expression of oriPtLs showed that it contributes to global viral lytic gene expression and viral DNA replication. Together, these results show that these new vlncRNAs interact with cellular innate immune pathways and that they help facilitate progression of the viral lytic cascade. Overall design: RNA-seq analysis for oriPtL knockdown and overexpression experiments
Sample: RNA-seq of control Mutu cells_2
SAMN03497732 • SRS918173 • All experiments • All runs
Library:
Instrument: Illumina HiSeq 2000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: Total RNA was isolated using TRIzol® Reagent (Life technologies, Cat. #15596-018) or a miRNeasy Mini Kit (Qiagen, Cat. #217004) following the respective vendor's protocols. Truseq strand specific protocol
Experiment attributes:
GEO Accession: GSM1664137
Links:
Runs: 1 run, 52.2M spots, 5.3G bases, 3.6Gb
Run# of Spots# of BasesSizePublished
SRR198451952,200,8205.3G3.6Gb2015-05-21

ID:
1456307

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...